Healthcare -
Biotechnology - NASDAQ - GB
$ 0.86
-1.15 %
$ 5.22 K
Market Cap
-0.33
P/E
AKTX - COST OF REVENUE
Cost of Revenue AKTX - Akari Therapeutics, Plc
4 K
LAST VALUE
-1.54%
2 YEAR CAGR
-35.51%
5 YEAR CAGR
0.00%
10 YEAR CAGR